ACV 1 is neuronal nicotinic receptor antagonist that displays selectivity for the α9α10 subtype. It can alleviates neuropathic pain in three rat models of human neuropathic pain and accelerate functional recovery of injured neurons.
ACV 1 is a synthetic peptide compound recognized for its relevance in neurobiological and cardiovascular research. Comprising a defined amino acid sequence, this peptide is derived from naturally occurring precursor proteins and has been extensively studied for its ability to interact with specific cellular receptors and signaling pathways. Its structural features and bioactive properties make it a valuable tool for investigating peptide-mediated physiological processes, particularly those involving neuropeptide signaling and vascular regulation. As a research-grade peptide, ACV 1 serves as a critical reagent for elucidating the mechanisms of peptide function in both in vitro and in vivo experimental systems.
Receptor Interaction Studies: ACV 1 is widely utilized in receptor binding assays to characterize its affinity and specificity for neuropeptide receptors. Researchers employ this peptide to map ligand-receptor interactions, enabling detailed analysis of receptor pharmacology and downstream signaling events. By serving as a model ligand, it facilitates the identification of receptor subtypes and the elucidation of structure-activity relationships, advancing the understanding of peptide-receptor dynamics at the molecular level.
Signal Transduction Research: The peptide is instrumental in dissecting intracellular signaling cascades triggered by neuropeptide engagement. Experimental models frequently use ACV 1 to stimulate or modulate second messenger systems, such as cyclic AMP or calcium flux, within neuronal and vascular cells. These studies provide insights into the mechanisms by which peptide ligands influence cellular responses, gene expression, and physiological outcomes, supporting the development of new hypotheses in cell signaling research.
Vascular Function Analysis: ACV 1 is applied in studies investigating the regulation of vascular tone and endothelial function. Its ability to mimic endogenous peptide activity allows researchers to probe the effects of peptide signaling on vasodilation, smooth muscle contractility, and endothelial cell communication. Through controlled application in isolated vessel preparations or cultured vascular cells, the peptide aids in delineating the molecular underpinnings of vascular homeostasis and reactivity.
Neurophysiological Investigations: In the context of neurobiology, ACV 1 is employed to examine the modulation of synaptic transmission and neural excitability. Electrophysiological experiments leverage the peptide to assess its influence on neurotransmitter release, neuronal firing patterns, and synaptic plasticity. Such studies contribute to a more comprehensive understanding of how peptide messengers participate in central and peripheral nervous system function, offering valuable data for basic neuroscience research.
Peptide Structure-Activity Relationship Studies: ACV 1 serves as a reference compound in comparative analyses aimed at defining the structural determinants of peptide bioactivity. By systematically modifying its amino acid sequence or chemical modifications, researchers can evaluate changes in receptor binding, signaling efficacy, and biological activity. These structure-activity relationship investigations are essential for advancing peptide engineering efforts, supporting the design of novel analogs with tailored functional properties for research applications.
Through these diverse applications, ACV 1 remains an indispensable reagent for advancing peptide science, providing researchers with a robust platform for probing the complexities of peptide-mediated signaling in both neural and vascular systems. Its versatility and well-characterized activity profile ensure ongoing utility in fundamental and applied research settings where precise modulation of peptide pathways is required.
1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
5. Implications of ligand-receptor binding kinetics on GLP-1R signalling
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More